Low molecular weight heparin for prevention of venous thromboembolism in patients with lower‐limb immobilization
AAG Zee, K van Lieshout… - Cochrane Database …, 2017 - cochranelibrary.com
Background Immobilization of the lower limb is a risk factor for venous thromboembolism
(VTE). Low molecular weight heparins (LMWHs) are anticoagulants, which might be used in …
(VTE). Low molecular weight heparins (LMWHs) are anticoagulants, which might be used in …
Low molecular weight heparin for prevention of venous thromboembolism in patients with lower-limb immobilization.
AA Zee, K van Lieshout, M van der Heide… - The Cochrane …, 2017 - europepmc.org
Background Immobilization of the lower limb is a risk factor for venous thromboembolism
(VTE). Low molecular weight heparins (LMWHs) are anticoagulants, which might be used in …
(VTE). Low molecular weight heparins (LMWHs) are anticoagulants, which might be used in …
[PDF][PDF] Low molecular weight heparin for prevention of venous thromboembolism in patients with lower-limb immobilization
AAG Zee, K van Lieshout, M van der Heide… - status and date: Edited …, 2017 - ktgh.com.tw
Background Immobilization of the lower limb is a risk factor for venous thromboembolism
(VTE). Low molecular weight heparins (LMWHs) are anticoagulants, which might be used in …
(VTE). Low molecular weight heparins (LMWHs) are anticoagulants, which might be used in …
[HTML][HTML] Low molecular weight heparin for prevention of venous thromboembolism in patients with lower‐limb immobilization
AAG Zee, K van Lieshout, M van der Heide… - The Cochrane …, 2017 - ncbi.nlm.nih.gov
Background Immobilization of the lower limb is a risk factor for venous thromboembolism
(VTE). Low molecular weight heparins (LMWHs) are anticoagulants, which might be used in …
(VTE). Low molecular weight heparins (LMWHs) are anticoagulants, which might be used in …
Low molecular weight heparin for prevention of venous thromboembolism in patients with lower-limb immobilization
AA Zee, K van Lieshout… - The Cochrane …, 2017 - pubmed.ncbi.nlm.nih.gov
Background Immobilization of the lower limb is a risk factor for venous thromboembolism
(VTE). Low molecular weight heparins (LMWHs) are anticoagulants, which might be used in …
(VTE). Low molecular weight heparins (LMWHs) are anticoagulants, which might be used in …
Low molecular weight heparin for prevention of venous thromboembolism in patients with lower‐limb immobilization
AAG Zee, K van Lieshout… - Cochrane Database …, 2017 - cochranelibrary.com
Background Immobilization of the lower limb is a risk factor for venous thromboembolism
(VTE). Low molecular weight heparins (LMWHs) are anticoagulants, which might be used in …
(VTE). Low molecular weight heparins (LMWHs) are anticoagulants, which might be used in …
[PDF][PDF] Low molecular weight heparin for prevention of venous thromboembolism in patients with lower-limb immobilization
AAG Zee, K van Lieshout, M van der Heide… - status and date: Edited …, 2017 - ktgh.com.tw
Background Immobilization of the lower limb is a risk factor for venous thromboembolism
(VTE). Low molecular weight heparins (LMWHs) are anticoagulants, which might be used in …
(VTE). Low molecular weight heparins (LMWHs) are anticoagulants, which might be used in …
Low molecular weight heparin for prevention of venous thromboembolism in patients with lower-limb immobilization.
AA Zee, K van Lieshout, M van der Heide… - The Cochrane …, 2017 - europepmc.org
Background Immobilization of the lower limb is a risk factor for venous thromboembolism
(VTE). Low molecular weight heparins (LMWHs) are anticoagulants, which might be used in …
(VTE). Low molecular weight heparins (LMWHs) are anticoagulants, which might be used in …